Incyte Corp/ US45337C1027 /
2024-04-15 9:59:56 PM | Chg. -0.43 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
53.42USD | -0.80% | 45,245 Turnover: 2.44 mill. |
-Bid Size: - | -Ask Size: - | 12 bill.USD | - | 20.01 |
GlobeNewswire
04-02
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire
04-01
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...
GlobeNewswire
02-28
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire
01-09
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
2023-12-09
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
GlobeNewswire
2023-11-16
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...
GlobeNewswire
2023-11-02
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
GlobeNewswire
2023-10-23
Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...
GlobeNewswire
2023-08-28
Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer
GlobeNewswire
2022-03-23
RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation An...
GlobeNewswire
2022-03-14
STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations
GlobeNewswire
2022-03-01
Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus R...
GlobeNewswire
2022-02-28
Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Up...
GlobeNewswire
2022-02-24
MacroGenics Provides Update on Corporate Progress and 2021 Financial Results
GlobeNewswire
2022-01-25
Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145
GlobeNewswire
2022-01-10
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agre...
GlobeNewswire
2021-12-15
AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Repigmentation...
GlobeNewswire
2021-12-06
Merus Presents Clinical Data on MCLA-145 at the ESMO Immuno-Oncology Congress 2021